For patients with relapsed or refractory multiple myeloma, combination treatment with elotuzumab, lenalidomide, and low-dose dexamethasone is generally well tolerated, with encouraging response rates, according to a study published online April 30 in theJournal of Clinical Oncology. (HealthDay) -- For ...
Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway. Cancer Lett. 2011;301:29-37.Kim HJ et al.Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway. Cancer Letters . 2011...
and a Multiple Myeloma wrist band. All of the above and a free ticket to See Chemo: A Survivors story. Other Ways You Can Help feel free to tell your friends, post the link to your facebook, donate to the American Cancer Society. Looking for more information? Check the project FAQ ...
Chemotherapy has proven to be a fairly successful treatment for cancer. But there’s one big problem: the drugs attack almost everything they touch. So what if we could only put it where it needs to go? that’s the idea behind a new type of cancer-fighting antibody, which scientists ...
γ-Tocotrienol and Met inhibitor SU11274 synergistically inhibited cell proliferation through downregulation of Akt, STAT, and NF-kB signaling in breast cancer cells + SA, MCF-7, and MDA-MB-231 Ayoub et al. [30,128] Thalidomide/Bortezomib γ-Tocotrienol sensitized the multiple myeloma tumor cells...
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy. Recent Results Cancer Res 1998; 144: 27–35. Article CAS Google Scholar Attal M, Harousseau JL . Standard therapy versus autologous transplantation in multiple myeloma. Hematol Oncol Clin ...
Ensuring Holistic, Individualized Transitions of Care for Cancer Survivors Andrew M. Evens, DO, MBA, MSc December 9th 2024 Podcast Andrew M. Evens, DO, MBA, MSc, discusses the importance of meeting the emotional and physical needs of cancer survivors to help them lead fruitful lives. ...
Diane Porter Hi, Anon, and thank you for your question. What kind of chemo are you taking? May I ask what kind of cancer you are being treated for? (It may help in researching your specific question). I found that it is not uncommon for people to have some allergic reactions to chem...
Effective and Well-Tolerated Combo in ER+/HER2– Metastatic Breast Cancer Kaklamani on Elacestrant for CDK4/6 Inhibitor-Naive ER+ Breast Cancer Treatment T-DXd in ER+/HER2-Low Breast Cancer: Insights From DESTINY-Breast06 Expanding Access to Bispecifics in R/R Multiple Myeloma Treatment Rea...
in breast cancer cell lines Ghada A. Abdel-Latif1, Ahmed M. Al-Abd2,3, Mariane G. Tadros1, Fahad A. Al-Abbasi4, Amany E. Khalifa1,5 & Ashraf B. Abdel-Naim1 Herceptin is considered an essential treatment option for double negative breast cancer. Resveratrol...